Follistatin: research, legal status and who sells it
This page is information, not medical advice. Follistatin is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- FS-344 (follistatin-344)
- Category
- Myostatin-binding protein
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $44.91/mg to $182.75/mg, median $111.96/mg across 12 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains follistatin [1]. |
| United Kingdom | No UK-licensed medicine containing follistatin appears in the MHRA products database [2]. |
| European Union | No medicine containing follistatin is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing follistatin appears in Health Canada's Drug Product Database [5]. |
| Australia | Schedule 4 (prescription-only) in Australia's Poisons Standard, with possession without authority prohibited under Appendix D [6]. |
| Sport (WADA) | Prohibited at all times as a myostatin-binding protein under S4 [7]. |
We haven't published a full overview of Follistatin yet. The legal status table and live prices on this page are current.
Follistatin prices: cheapest listings
The five lowest $/mg listings out of 16. See all Follistatin prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| BioLongevity Labs | 72 | Follistatin (FLGR242) (10mg) Subscription | 10 mg | $449 | $44.91/mg | View | |
| Geo Peptides | 52 | Follistatin 344 1mg - Untagged | 1 mg | $51 | $50.99/mg | View | |
| Geo Peptides | 52 | Follistatin 315 1mg - Untagged | 1 mg | $58 | $57.99/mg | View | |
| Peptides Warehouse | 62 | Follistatin 315 1mg – Untagged | 1 mg | $62 | $61.59/mg | View | |
| Go Alpha Labs | 83 | 1 mg × 10 | $800 | $80.00/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "follistatin". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026